Overview

Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

Status:
Completed

Trial end date:
2006-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine which dosages of dexmethylphenidate HCl extended-release capsules may represent effective treatment for ADHD in children 6-12 years of age.

Phase:

Phase 3

Details

Lead Sponsor:

Novartis

Treatments:

Dexmethylphenidate Hydrochloride